Characteristic (n=107) Frequency
Age (years), median (IQR) 78 (61 to 86)
Gender, n (%) female 58 (54.2%)
Clinical unit, n (%) Medical Surgical 63 (58.9%) 44 (41.1%)
Infection type (n=112) (%) intra-abdominal lower respiratory tract urinary tract skin and soft tissue prophylaxis gastro-intestinal tract Other 35 (31.2%) 31 (27.7%) 22 (19.6%) 15 (13.4%) 4 (3.8%) 2 (1.9%) 3 (2.7%)
Intravenous antimicrobials (n=164) (%) ceftriaxone amoxicillin-clavulanate metronidazole benzylpenicillin cefazolin azithromycin piperacillin-tazobactam ampicillin gentamicin flucloxacillin meropenem other 46 (28.0%) 25 (15.2%) 19 (11.6%) 14 (8.5%) 13 (7.9%) 10 (6.1%) 9 (5.5%) 7 (4.3%) 6 (3.7%) 4 (2.4%) 3 (1.8%) 8 (4.9%)